Indica Labs Upgrade Announcement
Indica Labs: HALO®, HALO AI, and HALO Link 3.5 are now available!
We are excited to announce that HALO®, HALO AI, and HALO Link 3.5 are now available for customers with active Software Maintenance and Support (SMS) plans.
In addition to software upgrades, SMS plans provide access to software patches and bug fixes between major releases and provide access to our world class technical and applications team, including software training.
If you have an active SMS plan entitling you to a software upgrade, you can click hereor the button below to initiate your upgrade(s).
Following submission of an upgrade request form, a member of our Technical Solutions Team will reach out via email to advise you of the earliest available installation appointments for your region and schedule your software upgrade(s) accordingly.
Please remember that our installations are scheduled according to our capacity to install, and we will schedule your installation appointment as soon as possible.
If you do not have an active SMS plan but would like to upgrade to 3.5, you will need to purchase SMS coverage for your product license(s). You can do so by clicking here or the button below.
3.5 Functionalities and Features
The 3.5 release of HALO has a new Crop Tool, improvements to the analysis job queue, and HALO Link permissions are better reflected. In addition, interactive markup images for the Area Quantification and Area Quantification FL modules enable users to explore colocalization and combined phenotypes.
HALO AI 3.5
In the 3.5 release of HALO AI, the Validation Workflow now utilizes Interactive Validation Markups to improve understanding of validation results. In addition, there is new functionality for the Phenotyper in analysis modules, and users can now import ONNX models and run analysis. New tools to optimize GPU utilization also provide workflow enhancements.
HALO Link 3.5
The 3.5 release of HALO Link includes new annotation tools and annotation export capabilities as well as an updated Admin Dashboard that provides administrators with a high-level overview of the system configuration and status. This release also includes new functionality on the Search page and the ability to create Box & Whisker and Violin plots to visualize trends.
3.5 Learning Portal Resources
Once your software has been upgraded, we recommend that you review the 3.5 release materials available in our Learning Portal listed below. You will need a learning portal account to access these resources. If you do not already have an account, you can create one here.
Documents
- HALO 3.5 User Guide
- HALO Area Quantification BF User Guide
- HALO Area Quantification FL User Guide
- HALO Link 3.5 User Guide
- HALO AI 3.5 User Guide
- HALO and HALO AI 3.5 Release Notes
- HALO Link 3.5 Release Notes
- HALO and HALO Link 3.5 Administrator Guide
Tutorial Videos
- HALO: Area Quantification BF
- HALO: Area Quantification FL
- HALO: Crop Tool
- HALO AI: Exporting ONNX models from HALO AI
- HALO AI: Importing ONNX models from HALO AI
- HALO AI: Finalizing a HALO AI network
- HALO Link: Annotation Tools
- HALO Link: Analysis Jobs and Plotting
- HALO Link: Utilizing the Search Page
Webinars
Questions?
Email support@indicalab.com and your local Applications Scientist and/or Technical Solutions Engineer will be available to answer any questions you may have on these releases.
If you have any questions regarding your SMS plan(s), please reach out to Julianna Lopez, Sales Operations Manager, at jlopez@indicalab.com or call 505-492-0979
About Indica Labs, Inc
Indica Labs is the world’s leading provider of computational pathology software and image analysis services. Our flagship HALO® and HALO AI platform facilitates quantitative evaluation of digital pathology images. HALO Link facilitates research-focused image management and collaboration while HALO AP® enables collaborative clinical case review. Through a combination of precision, performance, scalability, and usability our software solutions enable pharmaceutical companies, diagnostic labs, research organizations, and Indica’s own contract pharma services team to advance tissue-based research, clinical trials, and diagnostics.
SOURCE: Indica Labs, Inc
